Top Markets
Coin of the day
Becton, Dickinson and Company Becton, Dickinson and Company

Becton, Dickinson and Company

BDX
Κατάταξη σε μετοχές #389
Becton, Dickinson and Company develops, manufactures, and sells medical... Becton, Dickinson and Company develops, manufactures, and sells medical supplies, devices, laboratory equipment, and diagnostic products for healthcare institutions, physicians, life science researchers, clinical laboratories, pharmaceutical industry, and the general public worldwide. The company's BD Medical segment offers peripheral intravenous (IV) and advanced peripheral catheters, central lines, acute dialysis catheters, vascular care and preparation products, needle-free IV connectors and extensions sets, closed-system drug transfer devices, hazardous drug detections, hypodermic syringes and needles, anesthesia needles and trays, enteral syringes, and sharps disposal systems; IV medication and infusion therapy delivery systems, medication compounding workflow systems, automated medication dispensing and supply management systems, and medication inventory optimization and tracking systems; syringes, pen needles, and other products for diabetes; and prefillable drug delivery systems. Its BD Life Sciences segment provides specimen and blood collection products; automated blood and tuberculosis culturing, molecular testing, microorganism identification and drug susceptibility, and liquid-based cytology systems, as well as rapid diagnostic assays, microbiology laboratory automation products, and plated media products; and fluorescence-activated cell sorters and analyzers, antibodies and kits, reagent systems, and solutions for single-cell gene expression analysis, as well as clinical oncology, immunological, and transplantation diagnostic/monitoring reagents and analyzers. The company's BD Interventional segment offers hernia and soft tissue repair, biological and bioresorbable grafts, biosurgery, and other surgical products; surgical infection prevention, surgical and laparoscopic instrumentation products; peripheral intervention products; and urology and critical care products. The company was founded in 1897 and is based in Franklin Lakes, New Jersey.
Τιμή μετοχής
$154.51
Κεφαλαιοποίηση
$55.98B
Αλλαγή (1 ημέρα)
-1.82%
Αλλαγή (1 έτος)
-32.08%
Χώρα
US
Εμπόριο Becton, Dickinson and Company (BDX)

Κατηγορία

Αριθμός κυκλοφορούντων μετοχών για Becton, Dickinson and Company (BDX)
Αριθμός κυκλοφορούντων μετοχών στις December 2025: 285.07M
Σύμφωνα με τις τελευταίες οικονομικές αναφορές και την τιμή μετοχής της Becton, Dickinson and Company, ο τρέχων αριθμός κυκλοφορούντων μετοχών είναι 285.07M. Στο τέλος του September 2024, η εταιρεία είχε 289.76M κυκλοφορούντες μετοχές. Ο αριθμός των κυκλοφορούντων μετοχών επηρεάζεται συνήθως από διασπάσεις μετοχών και επαναγορές.
Ιστορικό κυκλοφορούντων μετοχών για Becton, Dickinson and Company (BDX) από 2000 έως 2026
Κυκλοφορούντες μετοχές στο τέλος κάθε έτους
Έτος Κυκλοφορούντες μετοχές Αλλαγή
2026 (TTM) 285.07M -0.54%
2025 286.61M -1.09%
2024 289.76M 1.22%
2023 286.28M 0.45%
2022 285.01M -1.48%
2021 289.29M 3.70%
2020 278.97M 3.34%
2019 269.94M 4.49%
2018 258.35M 18.00%
2017 218.94M 2.93%
2016 212.70M 5.02%
2015 202.54M 4.78%
2014 193.30M -0.95%
2013 195.16M -5.01%
2012 205.46M -7.11%
2011 221.18M -5.61%
2010 234.33M -2.56%
2009 240.48M -1.57%
2008 244.32M -0.35%
2007 245.19M -0.92%
2006 247.46M -1.62%
2005 251.53M 0.01%
2004 251.51M -1.19%
2003 254.54M -1.37%
2002 258.07M 0.27%
2001 257.37M 1.64%
2000 253.23M 0.00%
Κυκλοφορούντες μετοχές για παρόμοιες εταιρείες ή ανταγωνιστές
Εταιρεία Κυκλοφορούντες μετοχές Διαφορά Χώρα
354.90M 24.49%
US
345.26M 21.11%
DE
338.57M 18.77%
JP
489.30M 71.64%
CH
146.47M -48.62%
US